Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II

Recruiting N/A Interventional Study
Spine Degeneration Lumbar Degenerative Disease Frail Elderly Enhanced Recovery After Surgery (ERAS) Protocol Prehabilitation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
75 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
248 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This multicenter, parallel-group, assessor-blinded randomized controlled trial will enroll 248 adults aged ≥75 years with degenerative lumbar spinal diseases scheduled for elective lumbar fusion surgery, and they will be randomized 1:1 into the intervention and usual care groups. The intervention group will receive a 6-week PHYSIO-Prehab multimodal prehabilitation program, including multicomponent…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Aged ≥75 years at the time of screening 2. Voluntarily sign the informed consent form 3. Clinically diagnosed with degenerative lumbar spinal disorders with duration of symptoms \>6 months 4. Requiring elective lumbar fusion surgery (single-level or multi-level, open or minim…
Contacts

Shuaikang Wang, MD

15804084262

jackwangDR@163.com

CONTACT

Shibao Lu, Ph.D., MD

18301680586

2984335856@163.com

CONTACT